(Q43246257)

17 November 2017

0 references

Novel antipsychotics and the neuropsychological deficiencies of schizophrenia (English)

1 reference

17 November 2017

1 reference

1 reference

Hawkins KA

1

1 reference

17 November 2017

1 March 2000

1 reference

Journal of Psychiatry & Neuroscience

17 November 2017

1 reference

17 November 2017

25

1 reference

17 November 2017

2

1 reference

17 November 2017

105-107

1 reference

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

17 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1408046

What are the functional consequences of neurocognitive deficits in schizophrenia?

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1408046

Patient response and resource management: another view of clozapine treatment of schizophrenia

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1408046

A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1408046

Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1408046

Dimensions of outcome with clozapine

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1408046

The role of neurocognitive deficits in understanding adaptive functioning in severe psychiatric illness: commentary on Hawkins and Cooper

25 May 2018

1 reference

12 December 2020

Clozapine's effect on negative symptoms in treatment-refractory schizophrenics

1 reference

12 December 2020

Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]

1 reference

12 December 2020

Commentary on the clozapine conflict

1 reference

12 December 2020

Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia?

1 reference

12 December 2020

Identifiers

PMC publication ID

1408046

1 reference

PMC publication ID

1408046

17 November 2017

PubMed publication ID

10740983

1 reference

PMC publication ID

1408046